See more : Liquid Avatar Technologies Inc. (LQAVF) Income Statement Analysis – Financial Results
Complete financial analysis of Incannex Healthcare Limited (IXHL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Incannex Healthcare Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Fugro N.V. (FUR.AS) Income Statement Analysis – Financial Results
- HC SemiTek Corporation (300323.SZ) Income Statement Analysis – Financial Results
- Data Storage Corporation (DTST) Income Statement Analysis – Financial Results
- Euro Tech Holdings Company Limited (CLWT) Income Statement Analysis – Financial Results
- Hubei Heyuan Gas Co.,Ltd. (002971.SZ) Income Statement Analysis – Financial Results
Incannex Healthcare Limited (IXHL)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.incannex.com.au
About Incannex Healthcare Limited
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 12.00K | 0.00 | 540.17K | 1.42M | 417.45K | 1.09K | 749.19K | 216.77K | 68.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 4.38K | 683.84K | 310.80K | 0.00 | 387.89K | 396.97K | 48.92K | 13.76K | 430.76K | 757.99K | 1.22M | 41.75K | 391.02K | 0.00 | 0.00 | 0.00 | 15.29K |
Gross Profit | 12.00K | 0.00 | 535.79K | 739.07K | 106.65K | 1.09K | 361.30K | -180.20K | 19.38K | -13.76K | -430.76K | -757.99K | -1.22M | -41.75K | -391.02K | 0.00 | 0.00 | 0.00 | -15.29K |
Gross Profit Ratio | 100.00% | 0.00% | 99.19% | 51.94% | 25.55% | 100.00% | 48.23% | -83.13% | 28.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 12.88M | 41.66M | 3.71M | 3.54M | 1.46M | 516.81K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 16.83M | 7.93M | 193.99K | 74.31K | 315.85K | 231.80K | 573.43K | 612.04K | 268.89K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 348.00K | 84.00K | 1.90M | 3.26M | 280.35K | 66.56K | 901.40K | 423.04K | 53.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 17.17M | 8.01M | 4.66M | 4.84M | 1.35M | 375.15K | 2.58M | 1.85M | 509.60K | 486.81K | 397.05K | 1.37M | 1.15M | 2.73M | 361.62K | 513.85K | 826.11K | 839.29K | 107.68K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.49K | -93.16K | -202.43K | -152.02K | -180.81K | 0.00 | -131.67K | -27.52K | -24.19K |
Operating Expenses | 30.05M | 49.67M | 8.37M | 8.40M | 2.81M | 891.96K | 2.58M | 1.85M | 509.60K | 486.81K | 390.56K | 1.46M | 1.35M | 2.88M | 180.81K | 513.85K | 957.78K | 866.81K | 131.87K |
Cost & Expenses | 30.05M | 49.67M | 8.38M | 9.09M | 3.12M | 891.96K | 2.97M | 2.24M | 558.53K | -500.57K | -821.32K | -2.22M | -2.57M | -2.92M | -571.82K | -639.67K | -999.62K | -875.38K | -147.16K |
Interest Income | 206.00K | 244.01K | 4.55K | 2.00K | 3.05K | 1.11K | 2.36K | 6.53K | 424.25 | 3.18K | 16.34K | 122.80K | 126.22K | 99.59K | 32.62K | 6.91K | 224.50K | 44.01K | 1.18K |
Interest Expense | 0.00 | 3.01K | 218.07 | -10.46 | -89.80 | 60.83K | 9.98K | 37.56K | 89.76 | 99.84K | 160.04K | 195.54K | 194.91K | 93.67K | 107.56K | 35.09K | 10.92K | 5.05K | 15.59K |
Depreciation & Amortization | 103.00K | 23.00K | 7.84M | 7.64M | 28.91K | 29.95K | 42.33K | 23.27K | 11.93K | 13.76K | 36.25K | 29.41K | 42.58K | 41.75K | 45.15K | 41.29K | 41.84K | 8.56K | 340.77 |
EBITDA | -18.50M | -13.62M | 0.00 | 0.00 | -2.59M | -861.46K | -2.22M | -2.03M | -490.22K | -2.09M | -12.10M | -13.22M | -3.27M | -4.43M | 2.38M | -2.79M | -932.05K | -820.09K | -163.01K |
EBITDA Ratio | -154,200.00% | 0.00% | 0.00% | 0.00% | -619.34% | -79,012.56% | -295.87% | -935.19% | -717.71% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -30.04M | -49.67M | -7.84M | -7.66M | -2.70M | -890.87K | -2.22M | -2.03M | -490.22K | -500.57K | -821.32K | -2.22M | -2.57M | -2.92M | -571.82K | -639.67K | -999.62K | -875.38K | -147.16K |
Operating Income Ratio | -250,341.67% | 0.00% | -1,450.78% | -538.64% | -646.62% | -81,709.63% | -295.87% | -935.19% | -717.71% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 11.61M | 857.00K | -2.45M | -863.45K | -12.42K | -110.40K | -160.17K | -14.11M | -59.59K | -1.70M | -11.48M | -11.23M | -936.03K | -1.64M | 2.80M | -2.23M | 14.81K | 41.67K | -31.78K |
Income Before Tax | -18.43M | -48.81M | -10.29M | -8.53M | -2.71M | -1.00M | -2.38M | -16.14M | -549.82K | -2.20M | -12.30M | -13.45M | -3.51M | -4.56M | 2.23M | -2.87M | -984.81K | -833.71K | -178.94K |
Income Before Tax Ratio | -153,575.00% | 0.00% | -1,904.94% | -599.33% | -649.59% | -91,835.01% | -317.25% | -7,444.24% | -804.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 30.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -204.00K | -229.80K | 0.00 | -88.06K | -1.32M | -1.09M | -278.89K | 0.00 | 0.00 | -18.10K | 0.00 | 0.00 | 0.00 |
Net Income | -18.46M | -48.81M | -10.29M | -8.53M | -3.24M | -1.91M | -2.18M | -15.90M | -549.82K | -2.11M | -10.98M | -12.36M | -3.23M | -4.56M | 2.23M | -2.85M | -984.81K | -833.71K | -178.94K |
Net Income Ratio | -153,825.00% | 0.00% | -1,904.94% | -599.33% | -776.62% | -175,041.70% | -291.24% | -7,336.20% | -804.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -1.14 | -3.17 | -0.03 | -0.03 | -0.02 | -0.01 | -0.04 | -0.50 | -0.04 | -0.17 | -1.08 | -1.34 | -0.50 | -1.07 | 0.90 | -1.72 | -0.73 | -1.18 | -0.37 |
EPS Diluted | -1.14 | -3.17 | -0.03 | -0.03 | -0.02 | -0.01 | -0.04 | -0.50 | -0.04 | -0.17 | -1.08 | -1.34 | -0.50 | -0.73 | 0.51 | -1.72 | -0.73 | -1.13 | -0.37 |
Weighted Avg Shares Out | 16.16M | 15.38M | 297.79M | 244.23M | 171.01M | 111.86M | 57.00M | 31.91M | 15.69M | 12.11M | 10.20M | 9.21M | 6.50M | 4.05M | 2.47M | 1.65M | 1.35M | 706.01K | 481.06K |
Weighted Avg Shares Out (Dil) | 16.16M | 15.38M | 297.79M | 244.23M | 171.01M | 111.86M | 57.00M | 31.91M | 15.69M | 12.11M | 10.20M | 9.21M | 6.50M | 5.88M | 4.37M | 1.65M | 1.35M | 738.99K | 481.06K |
What's Going On With Incannex Healthcare's Stock Today?
The 7 Hottest Cannabis Stocks To Watch This Week
Cannabis Sector Kicks Off March With a Blast of Q4 Earnings
Source: https://incomestatements.info
Category: Stock Reports